A HeLa cell imaging agent
The preparation of HeLa cell imaging agent by introducing carbon dots into silica is solved by solving the problem of easy quenching of fluorescent signals and poor anti-background interference ability in the prior art, and efficient two-photon fluorescence and phosphorescence imaging is achieved. The imaging effect is significantly improved and the existence of long-lived components is confirmed.
Patent Information
- Application Number
- CN202410556929.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-07
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-05-07
AI Technical Summary
The fluorescence signals of existing HeLa cell markers are easily quenched, have poor anti-photobleaching ability and poor anti-background interference ability, making it difficult to achieve efficient two-photon fluorescence and phosphorescence imaging.
By introducing carbon dots into the gradually formed silica, HeLa cell imaging agent is prepared by reflux method, and the close coupling effect and mosaic between the carbon dots and silica is achieved, and a composite material with two-photon fluorescence and phosphorescence imaging capabilities is constructed.
The efficient preparation of HeLa cell imaging agents has been achieved, which significantly improves the afterglow signal of composite materials, has two-photon excitation fluorescence and phosphorescence imaging capabilities, can provide deeper penetration depth and lower phototoxicity in cell imaging, and through nano- The second transient absorption technology detects the light-induced absorption phenomenon, confirming the existence of long-lived components.
Smart Images

Figure CN118479463B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of cell imaging, and in particular to a HeLa cell imaging agent. Background Art
[0002] Existing HeLa cell markers are generally small organic molecules, which are generally oil-soluble and need to be processed to be water-soluble; and they are generally labeled with ordinary fluorescent signals, which are usually easily quenched, have poor resistance to photobleaching, and poor resistance to background interference. The two-photon fluorescence imaging and phosphorescence imaging capabilities of the complex can well make up for these defects.
[0003] In view of this, it is of great significance to develop HeLa cell imaging agents with two-photon fluorescence imaging and phosphorescence imaging capabilities. Summary of the invention
[0004] In order to solve the above problems, the present invention provides a HeLa cell imaging agent.
[0005] In a first aspect, the present invention provides a method for preparing a HeLa cell imaging agent, the method for preparing the HeLa cell imaging agent comprising the following steps:
[0006] Powdered carbon dots are obtained;
[0007] Dissolving the powdered carbon dots in water, and then adding tetraethyl orthosilicate and ammonia water to obtain a mixed solution;
[0008] The mixed solution is heated to reflux reaction to obtain a crude HeLa cell imaging agent;
[0009] The crude HeLa cell imaging agent is centrifuged to remove the precipitate, and then dialyzed to obtain the HeLa cell imaging agent.
[0010] Furthermore, the step of obtaining powdered carbon dots includes the following process:
[0011] Dissolving polyvinyl alcohol in water, and then mixing with ethylenediamine to obtain a first mixed solution;
[0012] subjecting the first mixed solution to a hydrothermal reaction to obtain a crude reaction product;
[0013] Acetone is added to the crude reaction product to carry out a precipitation reaction, followed by filtration and freeze-drying to obtain the powdered carbon dots.
[0014] Furthermore, the molecular weight of the polyvinyl alcohol is 1000-5000; based on 1g of polyvinyl alcohol, the added amount of ethylenediamine is 0.5-1.0mL.
[0015] Furthermore, the working parameters of the hydrothermal reaction include: temperature of 200-240° C. and time of 8-12 hours.
[0016] Furthermore, the working parameters of the hydrothermal reaction include: temperature of 220° C. and time of 10 h.
[0017] Furthermore, based on 1 mg of the powdered carbon dots, the added amounts of the tetraethyl orthosilicate and the ammonia water are 0.3-0.5 mL and 80-120 μL, respectively.
[0018] Furthermore, the working parameters of the heating reflux reaction include: temperature of 100-110° C. and time of 4-6 hours.
[0019] Furthermore, the working parameters of the heating reflux reaction include: temperature of 100° C. and time of 5 h.
[0020] In a second aspect, the present invention provides a HeLa cell imaging agent, wherein the HeLa cell imaging agent is prepared by the preparation method described in any one of the first aspects.
[0021] The above technical solution provided by the embodiment of the present invention has at least the following advantages compared with the prior art:
[0022] The embodiment of the present invention provides a HeLa cell imaging agent, which introduces carbon dots in the process of gradually forming silica by a reflux method, so that the coupling effect between the carbon dots and silica is tighter, and the mosaic effect between the carbon dots and silica is more obvious, thereby achieving efficient preparation of the HeLa cell imaging agent. Specifically:
[0023] The present invention embeds CDs into silica to construct a HeLa cell imaging agent, achieving efficient long afterglow in powder and water (including TADF component and phosphorescent component). At the same time, the conversion process from saturated absorption (SA) to anti-saturated absorption was observed when the monitoring light source was a 760nm ultrafast femtosecond laser. The two-photon excited fluorescence (2PEF) characteristics of the HeLa cell imaging agent composite material have also been successfully confirmed and further applied to biological imaging, which is more conducive to cell imaging compared with 1PEF. In addition, the phosphorescent signal from the HeLa cell imaging agent was also successfully carried out in HeLa cancer cell imaging. In addition, the photoinduced absorption (PIA) phenomenon was observed for the first time in CDs-based nanomaterials by nanosecond transient absorption (ns-TA) spectroscopy, and the detected PIA reached a peak at 466nm, including a "faster component" and a "slower component". The HeLa cell imaging agent has two-photon fluorescence imaging and phosphorescence imaging capabilities. The PIA signal was collected with the help of ns-TA technology. The existence of the PIA signal is used to confirm the long-lived components. This is a supplement and improvement to the technical means or characterization methods commonly used to confirm long-lived components, and has broad practical application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and, together with the description, serve to explain the principles of the invention.
[0025] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative labor.
[0026] Figure 1 The present invention provides a flow chart of a method for preparing a HeLa cell imaging agent.
[0027] Figure 2 It is a schematic diagram of the assembly process of the HeLa cell imaging agent of the present invention and the cell imaging of the photoluminescent HeLa cell imaging agent.
[0028] Figure 3 TEM image of CDs in the present invention.
[0029] Figure 4 This is a TEM image of the HeLa cell imaging agent of the present invention.
[0030] Figure 5 The HeLa cell imaging agent powder (top) and HeLa cell imaging agent solution photographed under sunlight and 365nm ultraviolet light in the present invention are shown in FIG.
[0031] Photographs of the liquid (bottom), and photos collected within 20 seconds after the light source was turned off.
[0032] Figure 6 It is the UV-visible absorption spectrum of the HeLa cell imaging agent in the present invention.
[0033] Figure 7 It is the fluorescence spectrum diagram of the HeLa cell imaging agent in the present invention.
[0034] Figure 8 It is the phosphorescence spectrum of the HeLa cell imaging agent in the present invention.
[0035] Fig. 9 This is a photoluminescence spectrum of the HeLa cell imaging agent of the present invention when excited by a 760nm ultrafast femtosecond laser with a power range of 12-80mW.
[0036] Fig.10 It is a Log-Log plot of the integrated photoluminescence intensity of the HeLa cell imaging agent of the present invention versus the excitation light source power.
[0037] Fig.11 Schematic diagram of the 1P / 2P excitation fluorescence process, TADF process and phosphorescence process of the HeLa cell imaging agent in the present invention.
[0038] Fig.12 The photoluminescence spectra of the HeLa cell imaging agent of the present invention at 340 nm under different delayed light source durations are shown.
[0039] Fig.13 It is the normalized fluorescence and phosphorescence spectra of the HeLa cell imaging agent of the present invention at an excitation wavelength of 340 nm at 80K.
[0040] Fig.14 It is a two-dimensional diagram of PL intensity and temperature of the HeLa cell imaging agent of the present invention.
[0041] Fig.15 Graph showing the temperature-dependent transient PL decay curve of the HeLa cell imaging agent of the present invention.
[0042] Fig.16 This is a graph showing the average lifespan test results of the HeLa cell imaging agent of the present invention at different temperatures.
[0043] Fig.17 The transient absorption spectra of HeLa cell imaging agent solution at different time delays.
[0044] Fig.18 The decay trace of HeLa cell imaging agent solution was detected at 466nm.
[0045] Fig.19 This is the two-photon excitation fluorescence (2PEF) imaging of HeLa cells treated with HeLa cell imaging agent under 760nm ultrafast femtosecond laser excitation.
[0046] Fig. 20 This is the phosphorescence imaging of HeLa cells by HeLa cell imaging agent at an excitation wavelength of 340nm. DETAILED DESCRIPTION
[0047] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0048] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.
[0049] The characterization of the long-life component (phosphorescence) in the long afterglow performance of carbon dots and silica composites was carried out by using the ns-TA technology, which confirmed the presence of the PIA (photo-induced absorption) signal in the composite material. The presence of this signal indicates that the composite material has a long-life component (seconds), that is, a long phosphorescence lifetime component. This is rarely reported in the field of carbon dots. Literature reports that the confirmation of phosphorescence components is generally determined by means of phosphorescence spectra, variable temperature spectra, lifetime, etc.
[0050] With the help of 760nm ultrafast femtosecond laser, the detection under the power of 12mW to 80mW shows a double exponential linear relationship between the PL signal and the power, which confirms the two-photon emission performance. Since the two-photon fluorescence signal has the advantages of deeper penetration depth and lower phototoxicity compared with the single-photon fluorescence signal, it was then applied to HeLa cell imaging and has a bright imaging effect. At the same time, compared with the fluorescence signal, the phosphorescence signal can almost achieve no background light interference in biological imaging. The complex was also introduced into HeLa cells, and the phosphorescence signal was also observed.
[0051] In a first aspect, the present invention provides a HeLa cell imaging agent, such as Figure 1 As shown, the preparation method of the HeLa cell imaging agent comprises the following steps:
[0052] Powdered carbon dots are obtained;
[0053] Dissolving the powdered carbon dots in water, and then adding tetraethyl orthosilicate and ammonia water to obtain a mixed solution;
[0054] The mixed solution is heated to reflux reaction to obtain a crude HeLa cell imaging agent;
[0055] The crude HeLa cell imaging agent is centrifuged to remove the precipitate, and then dialyzed to obtain the HeLa cell imaging agent.
[0056] The embodiment of the present invention provides a method for preparing a HeLa cell imaging agent. The present invention introduces carbon dots in the process of gradually forming silicon dioxide by a reflux method, so that the coupling effect between the carbon dots and silicon dioxide is closer, and the mosaic effect between the carbon dots and silicon dioxide is more obvious, thereby achieving efficient preparation of the HeLa cell imaging agent. Specifically:
[0057] 1) In the prior art, most of the preparations of HeLa cell imaging agents are to first synthesize carbon dots and silicon dioxide separately, and then form a composite by reflux method, stirring method or hydrothermal method. The afterglow signal of the obtained composite generally comes from the carbon dots. If the carbon dots before the composite have no afterglow, or the afterglow signal is very weak, the obtained composite will not be significantly improved. However, in this patent, the afterglow signal of the obtained composite is significantly improved compared with that of pure carbon dots. The afterglow signal that can be identified by the naked eye is as long as 20 seconds, and the afterglow signal also triggers the generation of delayed fluorescence signal; before the formation of HeLa cell imaging agent, the weak afterglow signal of pure carbon dots only comes from the phosphorescence component, and there is no delayed fluorescence component, and the afterglow of pure carbon dots cannot be observed by the naked eye. The "one-step method" involved in the reflux process simultaneously forms a HeLa cell imaging agent with carbon dots and silicon dioxide, and the HeLa cell imaging agent exhibits a long afterglow signal in both liquid and solid states, and the afterglow signal is also significantly improved after the composite. The existing reported composite methods only have long afterglow signals in the solid state, and it is difficult to have long afterglow signals in the liquid state.
[0058] 2) The present invention embeds CDs into silica to construct a HeLa cell imaging agent, achieving efficient long afterglow in powder and water (including TADF component and phosphorescent component). At the same time, the conversion process from saturated absorption (SA) to anti-saturated absorption was observed when the monitoring light source was a 760nm ultrafast femtosecond laser. The two-photon excited fluorescence (2PEF) characteristics of the HeLa cell imaging agent composite material have also been successfully confirmed and further applied to biological imaging, which is more conducive to cell imaging compared with 1PEF. In addition, the phosphorescence signal from the HeLa cell imaging agent was also successfully carried out in HeLa cancer cell imaging. In addition, the photoinduced absorption (PIA) phenomenon was observed for the first time in CDs-based nanomaterials by nanosecond transient absorption (ns-TA) spectroscopy, and the detected PIA reached a peak at 466nm, including a "faster component" and a "slower component". The HeLa cell imaging agent has two-photon fluorescence imaging and phosphorescence imaging capabilities. The PIA signal was collected with the help of ns-TA technology. The existence of the PIA signal is used to confirm the long-lived components. This is a supplement and improvement to the technical means or characterization methods commonly used to confirm long-lived components, and has broad practical application value.
[0059] In some specific embodiments, the step of obtaining powdered carbon dots comprises the following process:
[0060] Dissolving polyvinyl alcohol in water, and then mixing with ethylenediamine to obtain a first mixed solution;
[0061] subjecting the first mixed solution to a hydrothermal reaction to obtain a crude reaction product;
[0062] Acetone is added to the crude reaction product to carry out a precipitation reaction, followed by filtration and freeze-drying to obtain the powdered carbon dots.
[0063] In some specific embodiments, the molecular weight of the polyvinyl alcohol is 1000-5000; based on 1 g of polyvinyl alcohol, the amount of ethylenediamine added is 0.5-1.0 mL.
[0064] In some specific embodiments, the working parameters of the hydrothermal reaction include: temperature of 200-240° C. and time of 8-12 h.
[0065] In some specific embodiments, the working parameters of the hydrothermal reaction include: temperature of 220° C. and time of 10 h.
[0066] In some specific embodiments, based on 1 mg of powdered carbon dots, the added amounts of the tetraethyl orthosilicate and the ammonia water are 0.3-0.5 mL and 80-120 μL, respectively.
[0067] In some specific embodiments, the working parameters of the heating reflux reaction include: temperature of 100-110° C. and time of 4-6 h.
[0068] In some specific embodiments, the working parameters of the heating reflux reaction include: temperature of 100° C. and time of 5 h.
[0069] In a second aspect, based on a general inventive concept, the present invention provides a HeLa cell imaging agent, wherein the HeLa cell imaging agent is prepared by the preparation method described in any one of the first aspects.
[0070] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended only to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples that do not specify specific conditions are usually measured according to national standards. If there is no corresponding national standard, then the conditions recommended by the manufacturer are followed.
[0071] Example 1
[0072] This example provides a HeLa cell imaging agent, and the preparation method of the HeLa cell imaging agent comprises the following steps:
[0073] Preparation of CDs: 1 g of PVA (polyvinyl alcohol, molecular weight: 1750±50) was dissolved in 20 ml of water, the PVA solution was mixed with 0.75 mL of ethylenediamine, and then transferred into an autoclave and reacted at 220°C for 10 h; after the reaction, the excess PVA was removed by acetone precipitation, the transparent solution was collected and concentrated, and further dialyzed to obtain powdered CDs;
[0074] Preparation of HeLa cell imaging agent: Pour 5 mg of the prepared carbon dot powder into 10 mL of water and mix well to obtain a carbon dot solution. Then, add 2 mL of tetraethyl orthosilicate and 500 μL of ammonia water to the carbon dot solution respectively. Reflux in an oil bath at 100°C for 5 hours to obtain a crude complex of the HeLa cell imaging agent. Centrifuge to remove the precipitate and dialyze for 2 days to obtain a pure solution of the HeLa cell imaging agent.
[0075] Example 2
[0076] This example provides a HeLa cell imaging agent, and the preparation method of the HeLa cell imaging agent comprises the following steps:
[0077] Preparation of CDs: 1 g of PVA (polyvinyl alcohol, molecular weight: 1750±50) was dissolved in 20 ml of water, the PVA solution was mixed with 0.75 mL of ethylenediamine, and then transferred into an autoclave for reaction at 240°C for 8 h; after the reaction, the excess PVA was removed by acetone precipitation, the transparent solution was collected and concentrated, and further dialyzed to obtain powdered CDs;
[0078] Preparation of HeLa cell imaging agent: Pour 5 mg of the prepared carbon dot powder into 10 mL of water and mix well to obtain a carbon dot solution. Then, add 2 mL of tetraethyl orthosilicate and 500 μL of ammonia water to the carbon dot solution respectively. Reflux in an oil bath at 100°C for 5 hours to obtain a crude complex of the HeLa cell imaging agent. Centrifuge to remove the precipitate and dialyze for 2 days to obtain a pure solution of the HeLa cell imaging agent.
[0079] Example 3
[0080] This example provides a HeLa cell imaging agent, and the preparation method of the HeLa cell imaging agent comprises the following steps:
[0081] Preparation of CDs: 1 g of PVA (polyvinyl alcohol, molecular weight: 1750±50) was dissolved in 20 ml of water, the PVA solution was mixed with 0.75 mL of ethylenediamine, and then transferred into an autoclave and reacted at 200°C for 12 h; after the reaction, the excess PVA was removed by acetone precipitation, the transparent solution was collected and concentrated, and further dialyzed to obtain powdered CDs;
[0082] Preparation of HeLa cell imaging agent: Pour 5 mg of the prepared carbon dot powder into 10 mL of water and mix well to obtain a carbon dot solution. Then, add 2 mL of tetraethyl orthosilicate and 500 μL of ammonia water to the carbon dot solution respectively. Reflux in an oil bath at 100°C for 5 hours to obtain a crude complex of the HeLa cell imaging agent. Centrifuge to remove the precipitate and dialyze for 2 days to obtain a pure solution of the HeLa cell imaging agent.
[0083] Test Case
[0084] In this example, the HeLa cell imaging agent obtained in the above Example 1 was subjected to performance testing and characterization.
[0085] 1) The assembly process and cell imaging schematic diagram of the photoluminescent HeLa cell imaging agent provided by the present invention are as follows Figure 2 As shown. During the assembly process, the weak phosphorescence signal emitted by CDs was continuously enhanced by the denser silica network. At the same time, thermally activated delayed fluorescence (TADF) was observed under UV light. The assembled HeLa cell imaging agent was incubated into typical human HeLa cancer cells for cell imaging.
[0086] 2) TEM images after hydrothermal reaction show that the diameter of carbon dots (CDs) is about 4 nm. Figure 3 After CDs were embedded in the nano-silica shell, the HeLa cell imaging agent was quasi-spherical and amorphous, as shown in the high-resolution TEM image ( Figure 4). The assembled composite still has a fairly small size of about 20 nm, which is beneficial for biomedical applications. Under 365 nm handheld UV light, the HeLa cell imaging agent can emit bright blue light, as shown in Figure 2. Figure 5 As shown. In addition, after the UV source was cut off, the HeLa cell imaging agent powder exhibited a light green luminescence, which could be recognized by the naked eye within 20 seconds and was an afterglow behavior. In addition, the HeLa cell imaging agent solution also exhibited similar emission behavior as the HeLa cell imaging agent powder under UV irradiation and when the UV lamp was removed. It is worth mentioning that after the CDs were anchored on the SiO2 shell, the afterglow emission was greatly enhanced because the afterglow from these pure CDs was too weak to be recognized by the human eye. Compared with CDs, TADF emission is also a new phenomenon triggered after the formation of the HeLa cell imaging agent.
[0087] 3) The UV-visible absorption spectrum, fluorescence spectrum and phosphorescence spectrum of the HeLa cell imaging agent of the present invention are respectively as follows: Figure 6 , Figure 7 and Figure 8 As shown; the photoluminescence spectrum of the HeLa cell imaging agent excited by a 760nm ultrafast femtosecond laser with a power range of 12-80mW is shown Fig. 9 As shown; the Log-Log diagram of the integrated intensity of photoluminescence of HeLa cell imaging agent versus the excitation light source power is shown Fig.10 As shown; the schematic diagram of 1P / 2P excitation fluorescence process, TADF process and phosphorescence process is shown in Fig.11 It is shown that the HeLa cell imaging agent of the present invention successfully exhibits linear optical 1PEF characteristics and nonlinear optical 2PEF characteristics.
[0088] 4) The photoluminescence spectra of the HeLa cell imaging agent of the present invention at 340 nm under different delayed light source durations are as follows: Fig.12 The normalized fluorescence and phosphorescence spectra of the HeLa cell imaging agent of the present invention at an excitation wavelength of 340 nm at 80K are shown in FIG. Fig.13 The two-dimensional graph of PL intensity and temperature of the HeLa cell imaging agent of the present invention is shown in Fig.14 The temperature-dependent transient PL decay curve of the HeLa cell imaging agent of the present invention (monitored at EM: 418nm, EX: 340nm) is shown in FIG. Fig.15 The average lifespan of the HeLa cell imaging agent of the present invention (monitored at EM: 418nm, EX: 340nm) at different temperatures is shown in Fig.16 shown.
[0089] 5) The transient absorption spectra of HeLa cell imaging agent solution at different time delays are shown in Figure 2. Fig.17As shown in Figure 1, the photoinduced absorption (PIA) phenomenon of the HeLa cell imaging agent solution was successfully observed by nanosecond transient absorption (ns-TA) spectroscopy, which showed that the PIA peak was at about 466nm after a delay of 10-1000ms in the probe range of 400-800nm. The decay traces of the HeLa cell imaging agent solution were detected at 466nm as shown in Figure 1. Fig.18 As shown, a double exponential function fits the corresponding decay trajectory at 466 nm, which contains a "faster" process and a "slower" process, with decays of 357.4 ms and 8.4 s, respectively.
[0090] 6) Two-photon excitation fluorescence (2PEF) imaging of HeLa cells treated with HeLa cell imaging agent under 760nm ultrafast femtosecond laser excitation Fig.19 As shown in the figure. The phosphorescence imaging of HeLa cells by HeLa cell imaging agent at 340nm excitation wavelength is shown in Fig. 20 As shown. Compared with commercial dyes, the HeLa cell imaging agent prepared by the present invention has advantages in cell imaging. Commercial dyes have the disadvantages of severe photobleaching, poor solubility in water, narrow Stokes shift, complex dyeing process, and high cost. The HeLa cell imaging agent of the present invention is incubated into HeLa cancer cells for imaging applications. 2PEF imaging signals are collected under 760nm ultrafast femtosecond laser excitation, as shown Fig.19 As shown in Figures ac, the fluorescence signal is bright. The present invention also explores the potential of phosphorescence imaging, such as Fig. 20 As shown in Figures ac, the phosphorescence signal was also captured after the composite material was excited with a 340 nm light source. It is worth noting that the HeLa cell imaging agent only stained the HeLa cells for 20 minutes, and the obvious photoluminescence signal could be well dispersed in the cytoplasm region, indicating that the HeLa cell imaging agent could easily penetrate the cell membrane and enter the cancer cells. These properties indicate that the HeLa cell imaging agent has good cell penetration ability. Therefore, the HeLa cell imaging agent can be an excellent candidate for cell imaging.
[0091] Through the above tests, it can be known that: the present invention embeds CDs into silica to construct a HeLa cell imaging agent, and realizes efficient long afterglow in powder and water (including TADF component and phosphorescent component). At the same time, when the monitoring light source is a 760nm ultrafast femtosecond laser, the conversion process from saturated absorption (SA) to anti-saturated absorption is observed. The two-photon excited fluorescence (2PEF) characteristics of the HeLa cell imaging agent composite material have also been successfully confirmed and further applied to biological imaging, which is more conducive to cell imaging compared with 1PEF. In addition, the phosphorescence signal from the HeLa cell imaging agent was also successfully captured in the imaging of HeLa cancer cells. In addition, the photoinduced absorption (PIA) phenomenon was observed for the first time in CDs-based nanomaterials by nanosecond transient absorption (ns-TA) spectroscopy, and the detected PIA reached a peak at 466nm, including "faster components" and "slower components". The HeLa cell imaging agent has two-photon fluorescence imaging and phosphorescence imaging capabilities. The PIA signal was collected with the help of ns-TA technology. The existence of the PIA signal is used to confirm the long-lived components. This is a supplement and improvement to the technical means or characterization methods commonly used to confirm long-lived components, and has broad practical application value.
[0092] Various embodiments of the present invention may be presented in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity, and should not be understood as a rigid limitation on the scope of the present invention; therefore, the range description should be considered to have specifically disclosed all possible sub-ranges and single numerical values within the range. For example, the range description from 1 to 6 should be considered to have specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the range, such as 1, 2, 3, 4, 5 and 6, which apply regardless of the range. In addition, whenever a numerical range is indicated herein, it is meant to include any cited number (fractional or integer) within the indicated range.
[0093] The foregoing is merely a specific embodiment of the present invention, which enables those skilled in the art to understand or implement the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features claimed herein.
Claims
1. A HeLa cell imaging agent, characterized in that The preparation method of the HeLa cell imaging agent comprises the following steps: Dissolving polyvinyl alcohol in water, and then mixing with ethylenediamine to obtain a first mixed solution; subjecting the first mixed solution to a hydrothermal reaction to obtain a crude reaction product; Adding acetone to the crude reaction product for precipitation reaction, followed by filtering and freeze-drying to obtain powdered carbon dots; Dissolving the powdered carbon dots in water, and then adding tetraethyl orthosilicate and ammonia water to obtain a mixed solution; The mixed solution is heated to reflux reaction to obtain a crude HeLa cell imaging agent; Centrifuging the crude HeLa cell imaging agent to remove precipitate, and then dialyzing to obtain the HeLa cell imaging agent; The working parameters of the hydrothermal reaction include: a temperature of 200 to 240° C. and a time of 8 to 12 hours. The HeLa cell imaging agent has two-photon fluorescence imaging capabilities and phosphorescence imaging capabilities. The light-induced absorption phenomenon of the HeLa cell imaging agent solution was successfully observed through nanosecond transient absorption spectroscopy. The decay traces of the HeLa cell imaging agent solution detected at 466 nm included two processes with decay times of 357.4 ms and 8.4 s, respectively.
2. The HeLa cell imaging agent according to claim 1, characterized in that The molecular weight of the polyvinyl alcohol is 1000-5000; based on 1g of polyvinyl alcohol, the added amount of ethylenediamine is 0.5-1.0mL.
3. The HeLa cell imaging agent according to claim 1, characterized in that The working parameters of the hydrothermal reaction include: temperature of 220° C. and time of 10 h.
4. The HeLa cell imaging agent according to claim 1, characterized in that Based on 1 mg of powdered carbon dots, the added amounts of the tetraethyl orthosilicate and the ammonia water are 0.3-0.5 mL and 80-120 μL, respectively.
5. The HeLa cell imaging agent according to claim 1, characterized in that The working parameters of the heating reflux reaction include: temperature of 100-110° C. and time of 4-6 hours.
6. The HeLa cell imaging agent according to claim 1, characterized in that The working parameters of the heating reflux reaction include: temperature of 100° C. and time of 5 h.
Citation Information
Patent Citations
Organic functional luminescent carbon quantum dots, preparation method therefor and applications thereof
CN103421495A
Application of carbon dot @ inorganic oxide to preparation of anti-ultraviolet product
CN106521679A
Silicon dioxide-fluorescent carbon dot nanoparticles as well as preparation method and application thereof
CN107557002A
Preparation method of silicon dioxide coated carbon quantum dot composite material and application of silicon dioxide coated carbon quantum dot composite material in detection of different veterinary drug residues
CN113462377A
KR20220036544A
